As of 2024-12-12, the EV/EBITDA ratio of Diaceutics PLC (DXRX.L) is 15.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DXRX.L's latest enterprise value is 83.22 mil GBP. DXRX.L's TTM EBITDA according to its financial statements is 5.48 mil GBP. Dividing these 2 quantities gives us the above DXRX.L EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 23.0x | 18.4x |
| Forward P/E multiples | 9.4x - 25.0x | 16.6x |
| Fair Price | 49.23 - 167.13 | 104.98 |
| Upside | -57.7% - 43.5% | -9.9% |
| Date | EV/EBITDA |
| 2024-11-25 | 15.11 |
| 2024-11-22 | 15.34 |
| 2024-11-21 | 15.34 |
| 2024-11-20 | 15.49 |
| 2024-11-19 | 15.57 |
| 2024-11-18 | 15.42 |
| 2024-11-15 | 15.57 |
| 2024-11-14 | 15.73 |
| 2024-11-13 | 15.96 |
| 2024-11-12 | 15.96 |
| 2024-11-11 | 15.96 |
| 2024-11-08 | 15.96 |
| 2024-11-07 | 15.96 |
| 2024-11-06 | 15.96 |
| 2024-11-05 | 15.96 |
| 2024-11-04 | 15.96 |
| 2024-11-01 | 15.96 |
| 2024-10-31 | 15.96 |
| 2024-10-30 | 15.88 |
| 2024-10-29 | 15.34 |
| 2024-10-28 | 16.11 |
| 2024-10-25 | 16.27 |
| 2024-10-24 | 16.73 |
| 2024-10-23 | 16.81 |
| 2024-10-22 | 17.12 |
| 2024-10-21 | 17.58 |
| 2024-10-18 | 17.74 |
| 2024-10-17 | 17.82 |
| 2024-10-16 | 17.89 |
| 2024-10-15 | 17.82 |
| 2024-10-14 | 17.74 |
| 2024-10-11 | 17.74 |
| 2024-10-10 | 17.74 |
| 2024-10-09 | 17.74 |
| 2024-10-08 | 17.82 |
| 2024-10-07 | 17.82 |
| 2024-10-04 | 17.74 |
| 2024-10-03 | 17.82 |
| 2024-10-02 | 17.82 |
| 2024-10-01 | 17.82 |
| 2024-09-30 | 17.82 |
| 2024-09-27 | 17.82 |
| 2024-09-26 | 17.82 |
| 2024-09-25 | 17.82 |
| 2024-09-24 | 17.74 |
| 2024-09-23 | 17.82 |
| 2024-09-20 | 17.82 |
| 2024-09-19 | 17.74 |
| 2024-09-18 | 17.89 |
| 2024-09-17 | 17.66 |